2-hydroxy-5-nitrobenzylthioguanosine has been researched along with methylthioinosine in 1 studies
Studies (2-hydroxy-5-nitrobenzylthioguanosine) | Trials (2-hydroxy-5-nitrobenzylthioguanosine) | Recent Studies (post-2010) (2-hydroxy-5-nitrobenzylthioguanosine) | Studies (methylthioinosine) | Trials (methylthioinosine) | Recent Studies (post-2010) (methylthioinosine) |
---|---|---|---|---|---|
11 | 0 | 0 | 119 | 7 | 22 |
Protein | Taxonomy | 2-hydroxy-5-nitrobenzylthioguanosine (IC50) | methylthioinosine (IC50) |
---|---|---|---|
Adenosine kinase | Mycobacterium tuberculosis H37Rv | 2.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buolamwini, JK; Zhu, Z | 1 |
1 other study(ies) available for 2-hydroxy-5-nitrobenzylthioguanosine and methylthioinosine
Article | Year |
---|---|
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Topics: Drug Design; Equilibrative Nucleoside Transporter 1; Glycosides; Humans; K562 Cells; Models, Biological; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Static Electricity; Thioinosine | 2008 |